Bafna Pharmaceuticals Ltd
BAFNAPHBafna Pharmaceuticals Ltd
BAFNAPHPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
18.26 | 2.80 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.76 | 5.90 | 0.56% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Bafna Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged in the manufacture of drugs and medicines.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 143.66 | 86.55 | 66.10 | 78.43 | 44.02 | 42.73 | 71.97 | 86.84 | 118.62 | 156.58 | ||||||||||
Raw Materials | 72.56 | 65.99 | 55.01 | 34.19 | 27.00 | 23.22 | 33.58 | 41.70 | 65.98 | 137.46 | ||||||||||
Power & Fuel Cost | 1.85 | 2.38 | 2.01 | 2.12 | 2.50 | 2.69 | 2.95 | 3.93 | 5.31 | |||||||||||
Employee Cost | 10.34 | 6.44 | 6.62 | 7.47 | 9.01 | 10.25 | 11.98 | 14.65 | 15.87 | |||||||||||
Selling & Administrative Expenses | 9.16 | 3.30 | 3.15 | 4.07 | 3.13 | 3.18 | 2.67 | 6.92 | 5.39 | |||||||||||
Operating & Other expenses | 25.95 | 4.39 | 3.39 | 34.40 | 15.06 | 25.22 | 9.74 | 8.14 | 7.09 | |||||||||||
EBITDA | 23.80 | 4.05 | -4.08 | -3.82 | -12.68 | -21.83 | 11.05 | 11.50 | 18.98 | 19.12 | ||||||||||
Depreciation/Amortization | 5.24 | 4.11 | 3.89 | 3.65 | 3.42 | 3.27 | 4.48 | 5.49 | 5.33 | 5.25 | ||||||||||
PBIT | 18.56 | -0.06 | -7.97 | -7.47 | -16.10 | -25.10 | 6.57 | 6.01 | 13.65 | 13.87 | ||||||||||
Interest & Other Items | 12.48 | 12.47 | 11.34 | 6.81 | 2.13 | 0.10 | 0.74 | 0.79 | 2.04 | 2.32 | ||||||||||
PBT | 6.08 | -12.53 | -19.31 | -14.28 | -18.23 | -25.20 | 5.83 | 5.22 | 11.61 | 11.55 | ||||||||||
Taxes & Other Items | -0.03 | -0.34 | -0.84 | 2.18 | 1.50 | 0.00 | 0.00 | 0.00 | 0.28 | 0.28 | ||||||||||
Net Income | 6.11 | -12.19 | -18.47 | -16.46 | -19.73 | -25.20 | 5.83 | 5.22 | 11.33 | 11.27 | ||||||||||
EPS | 3.28 | -6.53 | -9.90 | -7.78 | -8.34 | -19.37 | 4.48 | 2.21 | 4.79 | 4.76 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Bafna Pharmaceuticals Ltd | 18.17 | 2.80 | — |
Sun Pharmaceutical Industries Ltd | 43.54 | 6.22 | 0.75% |
Cipla Ltd | 39.63 | 4.68 | 0.62% |
Dr Reddy's Laboratories Ltd | 22.35 | 4.33 | 0.66% |
Price Comparison
Compare BAFNAPH with any stock or ETFShareholdings
Promoter Holdings Trend
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 1.57%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
BAFNAPH has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 19, 2013
Dividend/Share
₹0.60
Ex DateEx Date
Sep 19, 2013
News & Opinions
Bafna Pharma Standalone December 2021 Net Sales at Rs 20.46 crore, up 17.08% Y-o-Y
2 years ago•Moneycontrol
Bafna Pharmaceuticals standalone net profit rises 88.89% in the December 2021 quarter
2 years ago•Business Standard
Bafna Pharma in talks with multinational pharma firms for brand acquisition
2 years ago•Free Press Journal
In talks with MNCs pharma cos for acquisition of brands: Bafna pharma
2 years ago•Business Standard
In talks with multinational pharma cos for acquisition of brands: Bafna pharmaceuticals
2 years ago•Economic Times
Bafna Pharma board to consider various avenues for raising funds
2 years ago•India Infoline
Bafna Pharmaceuticals standalone net profit rises 15.47% in the June 2021 quarter
2 years ago•Business Standard
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 8.63%, vs industry avg of 8.36%
Constant Market Share
Over the last 5 years, market share stayed at 0.04%